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Abstract
Background: The central circadian pacemaker is a remarkably robust regulator of daily rhythmic
variations of cardiovascular, endocrine, and neural physiology. Environmental lighting conditions
are powerful modulators of circadian rhythms, but regulation of circadian rhythms by disease states
is less clear. Here, we examine the effect of ischemic stroke on circadian rhythms in rats using high-
resolution pineal microdialysis.
Methods: Rats were housed in LD 12:12 h conditions and monitored by pineal microdialysis to
determine baseline melatonin timing profiles. After demonstration that the circadian expression of
melatonin was at steady state, rats were subjected to experimental stroke using two-hour
intralumenal filament occlusion of the middle cerebral artery. The animals were returned to their
cages, and melatonin monitoring was resumed. The timing of onset, offset, and duration of
melatonin secretion were calculated before and after stroke to determine changes in circadian
rhythms of melatonin secretion. At the end of the monitoring period, brains were analyzed to
determine infarct volume.
Results: Rats demonstrated immediate shifts in melatonin timing after stroke. We observed a
broad range of perturbations in melatonin timing in subsequent days, with rats exhibiting onset/
offset patterns which included: advance/advance, advance/delay, delay/advance, and delay/delay.
Melatonin rhythms displayed prolonged instability several days after stroke, with a majority of rats
showing a day-to-day alternation between advance and delay in melatonin onset and duration.
Duration of melatonin secretion changed in response to stroke, and this change was strongly
determined by the shift in melatonin onset time. There was no correlation between infarct size and
the direction or amplitude of melatonin phase shifting.
Conclusion: This is the first demonstration that stroke induces immediate changes in the timing
of pineal melatonin secretion, indicating that cortical and basal ganglia infarction impacts the timing
of melatonin rhythms. The heterogeneous direction and amplitude of melatonin shifts suggests that
the upstream regulation of hypothalamic timekeeping is likely anatomically diffuse and
mechanistically complex. Finally, our study exemplifies the use of pineal microdialysis to evaluate
the effect of neurological diseases on circadian function.
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Background
Stroke is a leading cause of death and disability world-
wide. While the immediate consequences of stroke
include permanent cognitive deficits, paralysis, visual
impairment, and sensory disturbances, stroke also results
in long term dysregulation of sleep and mood, which may
be equally disabling. The influence of ischemic stroke on
circadian rhythm regulation, which is strongly linked to
sleep and mood, may thus potentially influence long-
term recovery in stroke patients.
In humans, the daily expression of a multitude of physio-
logical variables is suppressed by ischemic stroke [1-8],
but limited work has been done to establish whether these
effects reflect true disruption of the circadian timing sys-
tem. To address the status of the central circadian pace-
maker, other investigators have measured melatonin after
stroke [9]. Beloosesky et al. [10] sampled urinary mela-
tonin metabolites every four hours and found that
rhythms persisted in all stroke patients, but the phase was
delayed by about 4 hours during the first day in patients
with extensive brain injury; the delay was not apparent 10
days after stroke. Fiorini et al. [11] measured urinary
melatonin every 12 hours after stroke and demonstrated
decreases in stroke patients that persisted for two weeks.
The precise timing of melatonin secretion could not be
determined in this study. Pang et al. [9] demonstrated that
intracerebral hemorrhage in a variety of locations inhibits
the production of melatonin measured by venipuncture.
The lack of longitudinal data in human subjects makes it
difficult to determine whether stroke induces changes in
circadian timing. In addition, the interpretation of these
studies is difficult, since standard medical care of acute
stroke patients by necessity requires nocturnal disruption
that may suppress melatonin and falsely imply changes in
circadian timing.
To overcome limitations of clinical studies, a small
number of experimental systems have been used to study
the effect of stroke on circadian regulation. Work in mice
has shown that sleep [12] is inhibited by ischemic stroke.
Spontaneously hypertensive stroke prone rats, which
spontaneously undergo both hemorrhagic and ischemic
stroke, exhibit blunting of heart rate and blood pressure
rhythms, but changes in circadian timing were not clear
[13]. The circadian variables in these studies have limited
time resolution and thus are insufficient to prospectively
quantify circadian phase changes.
Pineal microdialysis offers an exceptional technique for
measuring quantitative changes in circadian melatonin
secretion [14]. This method enables real time analysis of a
single individual, and therefore can prospectively measure
quantitative circadian responses to environmental
changes, pharmaceuticals, and potentially disease states.
In addition, the precise and sensitive measurement of pin-
eal melatonin permits the quantitative determination of
melatonin phase with up to 10-minute resolution. Pineal
melatonin is the most accurate marker of the central circa-
dian clock [15,16] and is not subject to pathological
masking that could be affected by the neurological com-
promise (eg. suppression of motor activity secondary to
hemiparesis, abulia, or ataxia after stroke). In this report,
we applied pineal microdialysis to determine whether
ischemic stroke in rats alters the circadian rhythm.
Methods
Animals
All experiments were performed in accordance with NIH
guidelines and approved by the University of Michigan
Committee on Use and Care of Animals. Adult male Wis-
tar rats (300 g) (Harlan) were housed at 20 to 25°C under
LD 12:12 h conditions, with ad libitum food and water.
Illumination levels were 300–400 lux at cage level.
Microdialysis probe implantation
Surgical placement of microdialysis probes was per-
formed as described [14]. Briefly, following deep anesthe-
sia, the animal's head was shaved and positioned in a
stereotaxic instrument with the head flat. Two small burr
holes were created on both sides of the skull. A custom
linear microdialysis probe was inserted carefully through
the burr holes into the brain tissue containing the pineal
gland and was connected with dialysis tubing at both
ends. Following surgery, animals were housed individu-
ally and allowed to recover for 16–24 h before microdial-
ysis.
Sample collection and analysis
Following recovery, animals were transferred to dialysis
chambers where their pineal glands were continuously
perfused with artificial cerebral spinal fluid at a low (2 ul/
min) rate via inlet tubing connected at one end of the
microdialysis probe. The outlet was connected to a sample
loop of an HPLC sample injector, which automatically
injected the collected pineal dialysates into an HPLC col-
umn at 10 min intervals. Melatonin in the dialysates was
resolved on a C18 reverse phase column and flow through
was analyzed by a fluorescence detector controlled by Shi-
madzu software.
Middle cerebral artery occlusion
Animals were subjected to ischemic stroke by filament
occlusion of the middle cerebral artery (MCA) after base-
line melatonin monitoring. The stroke model has been
described before [17,18]. Animals were taken off of mela-
tonin monitoring for the stroke surgery 3–6 days after the
initiation of on-line microdialysis during which time
baseline melatonin profiles were obtained. We occluded
the right MCA for two hours using an intralumenal fila-Journal of Circadian Rhythms 2008, 6:9 http://www.jcircadianrhythms.com/content/6/1/9
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ment and then removed the filament to allow reperfusion.
We placed the animals back online for pineal microdialy-
sis and continued melatonin monitoring for up to seven
days or until the animal appeared in extremis (whereupon
it was euthanized). At the end of the monitoring period,
animals were euthanized and brains were cut into 2 mm
thick sections and analyzed by 2% 2,3,5-triphenyltetrazo-
lium chloride (TTC) staining to quantify infarct volumes;
TTC stains vital tissue red while dead tissue remains
unstained. Infarct volumes were determined by analysis of
imaged brains using NIH Image software. Sham surgery
involved insertion of the filament into the carotid artery
without advancing the suture to the MCA bifurcation.
Statistics
To determine the level of statistical significance of circa-
dian changes, we first calculated the average absolute
deviation from the baseline melatonin onset (MT-on) for
each day after stroke for each animal. We used the average
of pre-stroke MT-on times as the baseline. We then com-
puted the absolute value of the difference between MT-on
and the baseline for each day that the animal was moni-
tored. Finally, we calculated the average value of the abso-
lute shift over the entire duration of the monitoring
period. This metric accounts equally for both delays and
advances in timing. The same calculation was performed
for sham animals after control surgery. The mean of the
average daily deviation for all animals in each group was
compared between MCA occlusion (MCAo) and sham
groups using a two-tailed t-test.
Results
Prior to stroke, we implanted Wistar rats (n = 14) with
pineal microdialysis probes and determined baseline
melatonin secretion patterns. Since this is an outbred
population, we observed a range of MT-on and melatonin
offset (MT-off) times (Figure 1), defined by the interval
between time of dark onset and time when the melatonin
rhythm reached 20% of its nightly maximum. The varia-
tion of MT-on and MT-off within the cohort has been
described previously [19]. Melatonin duration was calcu-
lated as the time difference between MT-on and MT-off.
Although there was variation within the cohort of circa-
dian profiles, individual rats prior to stroke showed virtu-
ally no day-to-day variation in MT-on, MT-off, or
Baseline melatonin profiles for rats prior to MCAo Figure 1
Baseline melatonin profiles for rats prior to MCAo. Melatonin profiles were obtained for all animals prior to MCAo to 
determine baseline timing. Measurements were made for up to six days, and, in all cases, the daily melatonin timing was stable. 
Therefore, only a single day's tracing of each individual is shown in this composite illustration. Animals exhibit a wide range of 
timing profiles. There is a broader range of MT-on times compared to MT-off times. The melatonin duration is defined as the 
time between the MT-on and MT-off. The MT-on is defined as the time when melatonin rises to 20% of the daily maximum (set 
to 100%). The MT-off is defined as the time when the melatonin level falls to 20% of the daily maximum. The gray shaded area 
represents time of lights off.
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melatonin duration over more than three days of baseline
observation, as described previously (14).
MCAo surgery was then performed on these animals. All
surgeries were initiated between 12:15 h and 14:34 h dur-
ing the day. Rats were then placed back on microdialysis
to measure post-surgical circadian melatonin profiles. We
could not record melatonin secretion from one animal,
and it was excluded from analysis. Two animals did not
show changes in melatonin secretion after MCAo. Eleven
of the remaining 13 rats exhibited temporal shifts in mela-
tonin secretion, beginning with the first night after MCAo
(Day 0); a representative rat is shown in Figure 2A. These
Effect of MCAo on rhythmic secretion of melatonin Figure 2
Effect of MCAo on rhythmic secretion of melatonin. Melatonin secretion was measured in animals before and after sur-
gery. Representative animals undergoing MCAo (A) and sham surgery (B) are shown. Tracings represent daily melatonin pro-
files superimposed upon the time of the day, with the gray shaded area representing lights off. Each day is demonstrated in a 
different color. D-2 and D-1 are two and one day before surgery. D0 is the day of the surgery, which was performed in the 
daytime. Days one to four (D1 to D4) are post-operative days. MCAo caused an advance of MT-on that persisted through four 
days of monitoring (A). MCAo slightly delayed the MT-off. Due to technical reasons, the data for the third postoperative day 
was lost (D3*). TTC stained brain sections are displayed to demonstrate that MCAo induces cortical and subcortical infarction. 
Sham surgery (B) did not affect MT-on or MT-off timing and did not cause brain infarction.
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rats demonstrated clear brain infarctions of the cortex and
basal ganglia, demonstrated by TTC staining (Figure 2A).
We also performed sham MCAo (control) surgery on six
rats that were analyzed by pineal microdialysis. These rats
had pre-surgical melatonin profiles that were similar to
the rats with MCAo. All six rats exhibited identical timing
of melatonin secretion before and after control surgery; a
representative animal is shown in Figure 2B; as expected,
TTC staining of control brains showed no infarction.
We examined the entire cohort of animals that exhibited
melatonin shifts to attempt to identify trends in circadian
behavior. Figure 3 shows the MT-on and MT-off profiles
for this set of rats. Surprisingly, the pattern of circadian
phase shifts in melatonin secretion showed a heteroge-
nous amplitude and direction of change. In general, how-
ever, the MT-on shifts were more pronounced than MT-off
shifts. The duration of melatonin secretion also exhibited
significant differences after stroke in these animals (Figure
4). The changes in melatonin duration varied in direction
and amplitude. When daily shifts of MT-on were averaged
following stroke surgery (a measure of deviation from
baseline – see methods), we observed a significant differ-
ence (p < 0.02) between sham and MCAo treated animals
(Figure 5).
As discussed above, the pre-stroke phase angle of MT-on
displayed variations within the cohort, indicating that
individual animals exhibited unique circadian parame-
ters. However, individual variations in MT-on time did
not correlate with the direction or amplitude of circadian
shifts after stroke (calculated on the initial day after the
stroke; Figure 6).
The direction of MT-on and MT-off shift (on the first night
after the stroke) demonstrated no correlation with each
other (Figure 7A). Roughly equal numbers of rats experi-
enced an advance in MT-on compared to delays, and
roughly half experienced advances in MT-off compared to
delays. We observed all four combinations of MT-on/MT-
off patterns (advance/advance, advance/delay, delay/
advance, and delay/delay). The change in MT-off was also
not associated with melatonin duration (Figure 7B).
Heterogeneous responses of melatonin timing after MCAo Figure 3
Heterogeneous responses of melatonin timing after MCAo. MT-on and MT-off times were obtained for each day of 
the experiment and are displayed in a composite timeline. Individual rats' melatonin profiles are depicted by unique colors. The 
left side shows MT-on tracings with black-filled circles, whereas the right side shows MT-off tracings with white-filled circles. 
As before, the day of MCAo was defined as Day 0. Due to technical difficulty, data was not available for some days for specific 
animals (dotted lines were used when days were skipped).
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Interestingly, the initial change in melatonin duration was
strongly linked to the initial change in MT-on after stroke
(Figure 7C). Thus, the change in melatonin duration after
stroke could be predicted by observing MT-on alone. This
relationship held true several days after the stroke, as well
(see below).
Due to early death (ID2832 and ID2837) and technical
reasons (ID2660, ID2842, and ID2896), we were not able
to quantify MT-on and MT-off for every day in every ani-
mal. However, in animals for which we had daily data for
extended periods, the MT-on and melatonin duration
demonstrate highly dynamic day-to-day changes after
stroke (Figures 8A and 8B); the change in MT-on and
melatonin duration from day-to-day exhibited an alter-
nating pattern, seeming to oscillate after stroke, albeit
with progressively decreasing amplitude. The waning of
day-to-day changes suggests that over time, the melatonin
onset and duration are reaching equilibrium at a new set
point. As on the first day after MCAo, MT-on and mela-
tonin duration changes over the course of a few days cor-
relate well with each other, indicating that the main
determinant of melatonin duration changes after stroke is
the MT-on shift (Figure 8C).
To determine whether circadian melatonin shifts were
related to the degree of infarction, we computed the area
of brain infarction using established morphometric meth-
ods. The range in infarction volume was typical of stroke
studies (30% +/-15%). We could not identify a correlation
between the degree of damage and either the direction or
the amplitude of initial changes in MT-on, MT-off, and
melatonin duration (Figure 9).
Melatonin production in the pineal gland is controlled by
a number of brain structures that include the SCN, par-
aventricular nucleus of the hypothalamus (PVN), and
intermediolateral nucleus of the spinal cord (IML). In
addition, the thalamic intergeniculate leaflet (IGL) [20]
modulates SCN activity, which may affect melatonin out-
put. Additionally, structures such as caudate putaman
(CPu) and parietal cortex are involved in locomotor
rhythm generation that can be dissociated from the SCN
signals [21], and may be affected in animals after stroke.
To determine whether specific regions affected by MCAo
were responsible for melatonin rhythm disruption, we
examined lesion sites of MCAo-treated animals. Of the
animals that exhibited shifts in melatonin rhythms, only
one showed injury near the SCN and only three animals
Effect of MCAo on the duration of nightly melatonin secretion Figure 4
Effect of MCAo on the duration of nightly melatonin secretion. Melatonin duration was calculated by computing the 
time between MT-on and MT-off for each day of the experiment. Since melatonin duration differs among individuals in the 
cohort, the melatonin duration was therefore normalized to the stable pre-stroke melatonin duration (set to 100%). Melatonin 
duration plots are displayed for each individual in a different color. As before, the day of MCAo was defined as Day 0. Dotted 
lines are used to signify days when data were not available for technical reasons.
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showed infarctions of the IGL. None of the animals had
injury to the PVN or IML. This indicates that injury to
these structures cannot account for the change in mela-
tonin timing after stroke. On the other hand, all animals
had significant injury to the CPu, and all but two animals
had cortical injury. Thus, CPu stroke is sufficient by itself
to disrupt normal melatonin rhythms.
Discussion
This is the first study to our knowledge that demonstrates
an effect of stroke on diurnal melatonin secretion in
experimental animals. Our experiments unequivocally
demonstrate that ischemic strokes in rats disrupt the tim-
ing of melatonin onset and/or offset, which are the most
consistent and direct markers of circadian timing. We also
demonstrate that pineal microdialysis is a highly sensitive
method for the study of modulation of the circadian pace-
maker by disease states.
Our prospective study design using pineal microdialysis
overcomes methodological limitations encountered in
human studies and in animal studies that utilize other cir-
cadian markers. Human studies are confounded by the
inability to measure pre-stroke circadian parameters, het-
erogeneity of stroke location, pre-existing medical condi-
tions, medications, neurological disability and the
unavoidable environmental variation required for medi-
cal care. As discussed above, melatonin is superior to
wheel running activity, core body temperature, and heart
rate as a marker for animal circadian timing; in addition,
melatonin is commonly used as a clock marker in human
studies [15].
In agreement with the human study by Beloosesky et
al[10], we show that in the acute phase of stroke, mela-
tonin rhythms are still present, but that the phase of mela-
tonin rhythms is shifted. Importantly, our experiments
give us added temporal resolution to quantify circadian
changes and to observe unique patterns of clock plasticity
after stroke. Our ability to examine individual melatonin
profiles reveals that there is dramatic heterogeneity in the
response of melatonin after stroke that cannot be detected
in human cohort observations.
We detected oscillatory behaviors in the MT-on alteration
and the melatonin duration change, which suggests that a
neuronal mechanism of non-pineal origin could be
responsible for reestablishing the steady state after
ischemic stress. The oscillatory melatonin rhythm demon-
strates that in the days after stroke, the circadian rhythm is
unstable. However, the oscillations dampen over days,
suggesting that the rhythm will ultimately reach an equi-
librium state with a stable melatonin rhythm similar to
the pre-stroke rhythm. Our finding that stroke induces
changes in melatonin secretion for several days differs
from the previous human studies [10]; we believe that our
results may be due to our ability to sample melatonin
with higher temporal resolution (20 minute vs. 240
minute increments) directly from the pineal gland (versus
a urinary metabolite).
We were surprised by the heterogeneity of melatonin
responses to stroke. Our data shows that the heterogeneity
is not related to a pre-existing circadian phenotype and is
not a result of differential damage to the hypothalamus,
which is spared in this model of stroke.
There may be several explanations for the heterogeneous
effects of stroke on circadian rhythms. We speculate that
diffusely distributed cortical and subcortical neurons exert
distinct effects on different sets of hypothalamic neurons.
Broadly distributed circadian controlling neurons may be
responsible for the highly variable changes in melatonin
secretion due to the stochastic nature of stroke injury,
which is in the same general territory, but varies subtly
from animal to animal. Alternatively, since stroke causes
massive releases of glutamate into the brain, it is possible
that glutamate diffusion into the hypothalamus results in
the disruption of hypothalamic clock neurons. The
regional spread and timing of glutamate release into the
Effect of MCAo on the shift of nightly melatonin onset Figure 5
Effect of MCAo on the shift of nightly melatonin 
onset. The impact of stroke on the melatonin rhythm for 
each animal was calculated by averaging the absolute daily 
melatonin onset shift (relative to pre-stroke baseline); see 
methods for a discussion of this calculation. The averages of 
these values determined for all animals with MCAo or sham 
surgery are displayed in bar graph format. The difference 
between average melatonin onset shift in the MCAo group 
was statistically significant relative to the control group (p < 
0.02).
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Lack of relationship between the phase angle of MT-on and the circadian response to MCAo Figure 6
Lack of relationship between the phase angle of MT-on and the circadian response to MCAo. As seen in Figure 1, 
rats demonstrate a wide range of baseline phase angles of MT-on. We explored the relationship between the phase angle (on 
the day of the stroke; shown on the X-axis) of MT-on, MT-off, and melatonin duration, relative to the baseline values before 
MCAo. The r2 values are shown; no relationship was found.
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Change in melatonin duration is related to the change in MT-on after MCAo Figure 7
Change in melatonin duration is related to the change in MT-on after MCAo. Results from the day of the MCAo 
were examined here. Data displayed include the change in MT-on, MT-off, and melatonin duration relative to respective pre-
MCAo values. (A) There was no relationship between shifts in MT-on and MT-off after stroke. Animals exhibited all four pos-
sible combinations of directions of shift. (B) There was no relationship between the shifts in MT-off and melatonin duration. 
(C) Change in the melatonin duration after stroke was strongly linked to the shift in MT-on. The r2 values are shown.






        
U  
$07RQK
$
0
7

G
X
U
D
W
L
R
Q


K

$
%
&





        
$
0
7

R
I
I


K

$07RQK
U  





   
$07GXUDWLRQK
$
0
7

R
I
I


K

U  Journal of Circadian Rhythms 2008, 6:9 http://www.jcircadianrhythms.com/content/6/1/9
Page 10 of 13
(page number not for citation purposes)
Day to day changes in MT parameters after stroke Figure 8
Day to day changes in MT parameters after stroke. The day-to-day changes in MT-on and melatonin duration were 
defined as the change in melatonin timing compared to the time on the previous day. As expected, on Day -1, there is no shift 
since the melatonin rhythm is stable. However, on Day 0 (the day of the stroke) there is a change in the melatonin timing com-
pared to before stroke. Only five animals, represented by different colors, were used for this analysis. Other animals in the 
study could not be used because of gaps in data. (A) MT-on changes markedly in most animals from day-to-day. In all animals, 
there is a remarkable oscillation of the daily changes in melatonin timing. In general, the amplitude of the oscillation decreases 
over time. (B) A similar trend is seen with the daily change in melatonin duration. (C) There is a strong relationship between 
the daily shift in MT-on and melatonin duration among most animals. The r2 coefficients (for each animal) were: 0.85 (ID2658), 
0.56 (ID2833), 0.15 (ID2839), 0.92 (ID2892), and 0.99 (ID2900).
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Infarct volume and its relationship to shift in MT timing Figure 9
Infarct volume and its relationship to shift in MT timing. Infarct volumes for all animals undergoing MCAo were com-
puted. Each rat's infarct volume was plotted against the Day 0 shift in MT-on, melatonin duration, or MT-off relative to the 
baseline time before stroke. There was no linear relationship between infarct volume and any of the quantitative measures of 
circadian changes. The r2 values are shown; no relationship was found.
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hypothalamus may differ between individuals, resulting
in individual-specific patterns of circadian disruption. It is
noteworthy that Wang et al. [5] described abnormalities
in the circadian rhythms of stroke patients which were
quantitatively dependent on the distance of the infarct
from the hypothalamus. Finally, novel genetic polymor-
phisms in outbred Wistar rats may impact the responses
of SCN neurons to cortical and basal ganglial injury.
In addition to the SCN, PVN and IML are important brain
structures controlling melatonin production. Only one rat
(ID2658) showed lesion near the SCN, whereas none of
the MCAo treated rats showed detectable injury in the
PVN region. MCAo surgery is known to spare the spinal
cord where IML is found. Thus, direct neuronal defects in
melatonin rhythm-generating machinery in the brain can
be ruled out as the cause of the melatonin rhythm disrup-
tions seen in our studies. Since brain structures such as
IGL [20] and Raphe nuclei send projections to the SCN,
injury in these regions could potentially affect melatonin
output. Upon careful examination, however, none of the
rats had lesions in the Raphe nuclei and only three rats
(ID2658, ID2639, and ID2896) showed lesion near the
IGL. There were no common features of melatonin shifts
in rats with IGL lesions compared to those with intact IGL.
Previous study also demonstrated involvement of CPu
and parietal cortex in locomotor rhythm regulation that
can be dissociated from the SCN [21]. In the same study,
melatonin rhythms were shown to be phase aligned with
the SCN clock gene expression and were not affected by
the free-running locomotor rhythms induced by drug
treatment [21]. MCAo treated rats in our cohort showed
lesions in both CPu (11 of 11 rats) and parietal cortex (8
of 11), two structures that are most consistently affected in
this model of stroke. These results suggest that stroke may
unmask interactions between the parietal/CPu locomotor
rhythm generating system and other SCN-driven rhythms
by yet unidentified mechanisms.
Our studies confirm the influence of the cortex and basal
ganglia on circadian rhythms. In fact, extrahypothalamic
mechanisms of circadian disruption have been described
in preclinical models of Huntington's disease [22] and
Alzheimer's disease [23]. Thus, uncovering the mecha-
nisms of how brain dysfunction outside the retinohypoth-
alamic pathway impacts circadian timekeeping may
ultimately lead to strategies to reduce the morbidity of
many neurological disorders. Our model of measuring
pineal melatonin after stroke may be useful in decipher-
ing these mechanisms, since it is quantitative and capable
of detecting longitudinal changes in the same animals.
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